As of 3:59pm ET
| -0.24 / -7.38%|
The 4 analysts offering 12-month price forecasts for aTyr Pharma Inc have a median target of 8.00, with a high estimate of 10.00 and a low estimate of 3.00. The median estimate represents a +165.78% increase from the last price of 3.01.
The current consensus among 4 polled investment analysts is to Hold stock in aTyr Pharma Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.